FDA Issues Final Cannabis Guidance on Clinical Research
FDA issued its final guidance, Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research. The agency outlines current recommendations for drug sponsors developing cannabis and cannabis-derived compounds for use in human drug clinical research.
National Institute On Drug Abuse Drug Enforcement Administration Drug Development Dec Drug Administration Drug Supply Program Cannabis Derived Compounds
Source: natlawreview.com